
Newsletter
Gut and vaginal microbiome testing and intelligence across the lifespan.
Tiny Health provides gut microbiome tests for babies, children and adults, a vaginal microbiome test and practitioner tools. Founded in 2020, it launched in 2022 with a baby gut microbiome test based on shotgun metagenomic sequencing. Powered by Tiny is its B2B testing platform, which the company says grew fourfold in the preceding year. TinyAI provides guidance trained on nearly 200,000 microbiome profiles. In September 2026, Tiny reported nearly 200,000 customers and more than 6,000 healthcare practitioners, alongside a $33 million Series B and a $5 million Microbiome Research Program.
Leadership as of 14 November 2026.
Founder
How Tiny Health got here, step by step.
2020
Founded in 2020 and launched in 2022 with the first gut microbiome test for babies built on shotgun metagenomic sequencing.
29 September 2026
Led by B Capital with Spero Ventures, The Venture City, Overwater Ventures and new investors; total funding $46 million; $5 million Microbiome Research Program launched.
29 September 2026
Tiny Health raises $33M Series BRelated companies
Your daily HealthTech Signal
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: